Bravelle (Generic Urofollitropin): Complete Medication Guide
Key Takeaways
Urofollitropin is a fertility medication that stimulates egg production in women undergoing assisted reproductive treatments.
It's a recombinant FSH (follicle-stimulating hormone) injection used primarily for in vitro fertilization (IVF) and other fertility procedures.
Common side effects include injection site reactions, headaches, and mild abdominal discomfort.
Serious side effects may include ovarian hyperstimulation syndrome (OHSS) and blood clots, requiring immediate medical attention.
Cost-effective generic versions are available as a cost-effective alternative to brand-name drugs.
Bravelle (Generic Urofollitropin) Overview
Urofollitropin is a fertility hormone medication that works by mimicking follicle-stimulating hormone (FSH), a naturally occurring hormone in the body. This medication is prescribed to stimulate the ovaries to produce multiple eggs during fertility treatment cycles. The drug is administered as a subcutaneous injection and is commonly used in assisted reproductive technologies like IVF, intrauterine insemination (IUI), and other fertility procedures.
Generic urofollitropin contains the same active ingredient as the brand-name Bravelle, making it an effective and more affordable option for many patients. Understanding generic vs brand-name drugs can help you make informed decisions about your fertility treatment plan. The medication helps regulate the menstrual cycle and promotes the development of ovarian follicles, which contain eggs needed for conception.
This information is educational and does not replace advice from your healthcare provider. Urofollitropin is typically prescribed as part of a comprehensive fertility treatment plan supervised by a reproductive endocrinologist or fertility specialist. The medication's effectiveness depends on proper administration, timing, and individualized dosing based on your body's response to treatment.
Side Effects
Urofollitropin is generally well-tolerated by most patients, though some individuals may experience mild to moderate side effects during their fertility treatment cycle.
Common Side Effects
Injection site reactions: Redness, swelling, bruising, or tenderness at the injection site are common and usually resolve within a few days.
Headaches: Mild to moderate headaches may occur and can often be managed with over-the-counter pain relievers.
Abdominal discomfort: Bloating, cramping, or mild pain in the lower abdomen may occur as the ovaries respond to stimulation.
Nausea: Some patients experience mild nausea, which typically subsides as the body adjusts to the medication.
Fatigue: Mild tiredness or low energy levels may occur during the stimulation cycle due to hormonal changes.
Mood changes: Irritability or emotional sensitivity may occur due to fluctuating hormone levels during treatment.
Serious Side Effects
Ovarian Hyperstimulation Syndrome (OHSS): Severe abdominal pain, rapid weight gain, shortness of breath, or decreased urination may indicate OHSS, a serious condition requiring immediate medical evaluation.
Blood clots: Pain, swelling, or warmth in the legs, chest pain, or difficulty breathing may indicate thromboembolism and require emergency care.
Allergic reactions: Severe rash, difficulty breathing, swelling of the face or throat, or anaphylaxis requires immediate emergency treatment.
Ovarian torsion: Severe, sudden abdominal or pelvic pain may indicate ovarian torsion, a medical emergency requiring urgent evaluation.
Cyst rupture: Sudden severe pain in the abdomen or pelvis may indicate a ruptured ovarian cyst and requires immediate medical attention.
When to Seek Medical Attention
Contact your healthcare provider immediately if you experience severe abdominal or pelvic pain, sudden weight gain exceeding two pounds per day, severe nausea or vomiting, decreased urination, shortness of breath, chest pain, or signs of allergic reaction during your treatment cycle. Do not wait to see if symptoms improve on their own—early intervention can prevent serious complications. Additionally, report any persistent headaches, signs of infection at injection sites, or unusual vaginal bleeding to your clinician promptly.
Dosage
Dose Level or Form |
Typical Dose |
Key Detail |
Standard Starting Dose |
75–150 IU daily |
Adjusted based on ovarian response; monitored with ultrasound and hormone levels |
Maintenance Dose |
75–300 IU daily |
Increased or decreased based on follicle development; varies by individual response |
Maximum Daily Dose |
Up to 450 IU daily |
Rarely exceeded; higher doses increase OHSS risk |
Treatment Duration |
8–14 days |
Cycle length varies; depends on follicle maturity and individual factors |
Administration |
Subcutaneous injection |
Injected under the skin; same site rotation recommended to prevent irritation |
Important: Never skip or double doses; follow your fertility specialist's instructions exactly. Do not stop urofollitropin without consulting your doctor, as premature discontinuation may compromise your treatment cycle. Store the medication as directed, keep all scheduled monitoring appointments, and report any concerns about your response to treatment immediately.
Drug Interactions
Urofollitropin has limited significant drug interactions, but certain medications and substances may affect your treatment response or increase side effect risks.
GnRH Agonists (Leuprolide, Goserelin)
These medications are often used together in fertility protocols to prevent premature ovulation. However, combining them requires careful timing and dosing adjustments by your fertility specialist to optimize your treatment cycle.
GnRH Antagonists (Cetrorelix, Ganirelix)
Similar to agonists, antagonists are frequently combined with urofollitropin in modern fertility protocols. The combination helps control your ovulation timing but requires precise coordination of injection schedules and medical monitoring.
Human Chorionic Gonadotropin (hCG)
hCG is typically given as a "trigger shot" after urofollitropin stimulation to finalize egg maturation before retrieval. This combination is a standard part of most IVF protocols and must be timed precisely for success.
Antibiotics (Certain Types)
While most antibiotics are safe with urofollitropin, some may affect hormone absorption or metabolism. Always inform your fertility specialist about any infections requiring antibiotic treatment during your cycle.
NSAIDs and Aspirin
While generally safe, high-dose or prolonged NSAID use during fertility treatment may affect ovulation or increase bleeding risk. Discuss pain management options with your fertility specialist.
Herbal Supplements
Certain herbal supplements may interfere with hormone metabolism or increase bleeding risk. Inform your clinician about all supplements, including vitamins and herbs, before starting treatment.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Effective at stimulating multiple egg production, improving chances of successful fertilization in IVF cycles.
Well-established safety profile when used under medical supervision with appropriate monitoring protocols.
Generic versions offer significant cost savings compared to brand-name alternatives, making fertility treatment more accessible.
Allows flexibility in dosing adjustments based on individual ovarian response as monitored through ultrasound.
Relatively simple subcutaneous injection administration that patients can learn to self-administer at home.
Cons
Risk of ovarian hyperstimulation syndrome (OHSS), a potentially serious complication requiring medical intervention.
Requires frequent monitoring appointments with ultrasounds and blood tests, adding time and expense to treatment.
Multiple pregnancy risk increases complications for both mother and babies compared to natural conception.
Injection site reactions, including pain, bruising, and swelling, are common during treatment cycles.
Significant out-of-pocket costs even with generic options, as fertility treatments are often not covered by insurance.
Frequently Asked Questions
Generic urofollitropin typically costs 20-40% less than brand-name Bravelle, offering substantial savings over a complete fertility cycle. However, prices vary by pharmacy, insurance coverage, and manufacturer. Many fertility clinics have partnerships with specific manufacturers offering discounts. Ask your clinic about available options and patient assistance programs to reduce costs further during treatment.
Yes, urofollitropin can be used with PCOS, but requires careful monitoring and dose adjustments. Women with PCOS are at higher risk for ovarian hyperstimulation syndrome (OHSS), so your fertility specialist may start with lower doses and closely monitor your response. More frequent ultrasounds and blood tests help ensure safe treatment progression throughout your cycle.
Success rates depend on many factors including age, egg quality, sperm quality, and overall reproductive health—not solely on urofollitropin. Younger women typically have higher success rates (40-50% per cycle), while success declines with advancing age. Your fertility specialist can provide personalized success rate estimates based on your individual circumstances and medical history.
Ovulation typically occurs 34-36 hours after the hCG "trigger shot," which is given after urofollitropin has stimulated sufficient follicle development. The total urofollitropin stimulation phase usually lasts 8-14 days, depending on how quickly your follicles develop. Your fertility specialist monitors development closely and times the trigger injection precisely for optimal egg retrieval during your IVF procedure.
Natural conception without medication is possible for some couples, but urofollitropin is specifically needed for IVF and certain fertility procedures. Lifestyle modifications like weight management, stress reduction, and healthy eating support fertility overall. However, if you have ovulation disorders or need assisted reproduction, your fertility specialist will explain why medication is necessary for your specific situation.
The Bottom Line
Generic urofollitropin (Bravelle) is an effective, well-established fertility medication that stimulates egg production for assisted reproductive procedures. When used under proper medical supervision with appropriate monitoring, it offers a safe pathway to fertility treatment for many patients. Common side effects are typically mild and manageable, though serious complications like OHSS require immediate attention. Understanding generic vs brand-name drugs helps you access affordable treatment options without compromising quality or effectiveness. The decision to use urofollitropin should be made in consultation with your fertility specialist, who can assess your individual circumstances and create a personalized treatment plan. Doctronic is here to support your health journey with expert medical guidance and affordable healthcare access—because taking control of your reproductive health should be accessible to everyone. Ready to take control of your health? Get started with Doctronic today.
